Ribonucleic acid-based therapy for Myocardial Infarction: LncRNA DGCR5  inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 17/January/2019, 12.04 am